BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 18252717)

  • 1. Identification of p300-targeted acetylated residues in GATA4 during hypertrophic responses in cardiac myocytes.
    Takaya T; Kawamura T; Morimoto T; Ono K; Kita T; Shimatsu A; Hasegawa K
    J Biol Chem; 2008 Apr; 283(15):9828-35. PubMed ID: 18252717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tyrosine phosphorylation of RACK1 triggers cardiomyocyte hypertrophy by regulating the interaction between p300 and GATA4.
    Suzuki H; Katanasaka Y; Sunagawa Y; Miyazaki Y; Funamoto M; Wada H; Hasegawa K; Morimoto T
    Biochim Biophys Acta; 2016 Sep; 1862(9):1544-57. PubMed ID: 27208796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metformin suppresses phenylephrine-induced hypertrophic responses by inhibiting p300-HAT activity in cardiomyocytes.
    Sunagawa Y; Shimizu K; Katayama A; Funamoto M; Shimizu K; Nurmila S; Shimizu S; Miyazaki Y; Katanasaka Y; Hasegawa K; Morimoto T
    J Pharmacol Sci; 2021 Oct; 147(2):169-175. PubMed ID: 34384564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aldosterone signaling associates with p300/GATA4 transcriptional pathway during the hypertrophic response of cardiomyocytes.
    Yoshida Y; Morimoto T; Takaya T; Kawamura T; Sunagawa Y; Wada H; Fujita M; Shimatsu A; Kita T; Hasegawa K
    Circ J; 2010 Jan; 74(1):156-62. PubMed ID: 19966502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiac p300 is involved in myocyte growth with decompensated heart failure.
    Yanazume T; Hasegawa K; Morimoto T; Kawamura T; Wada H; Matsumori A; Kawase Y; Hirai M; Kita T
    Mol Cell Biol; 2003 May; 23(10):3593-606. PubMed ID: 12724418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclin-dependent kinase-9 is a component of the p300/GATA4 complex required for phenylephrine-induced hypertrophy in cardiomyocytes.
    Sunagawa Y; Morimoto T; Takaya T; Kaichi S; Wada H; Kawamura T; Fujita M; Shimatsu A; Kita T; Hasegawa K
    J Biol Chem; 2010 Mar; 285(13):9556-9568. PubMed ID: 20081228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multimerization of the GATA4 transcription factor regulates transcriptional activity and cardiomyocyte hypertrophic response.
    Shimizu S; Sunagawa Y; Hajika N; Yorimitsu N; Katanasaka Y; Funamoto M; Miyazaki Y; Sari N; Shimizu K; Hasegawa K; Morimoto T
    Int J Biol Sci; 2022; 18(3):1079-1095. PubMed ID: 35173540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FOG-2 competes with GATA-4 for transcriptional coactivator p300 and represses hypertrophic responses in cardiac myocytes.
    Hirai M; Ono K; Morimoto T; Kawamura T; Wada H; Kita T; Hasegawa K
    J Biol Chem; 2004 Sep; 279(36):37640-50. PubMed ID: 15220332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcription factor GATA4 is activated but not required for insulin-like growth factor 1 (IGF1)-induced cardiac hypertrophy.
    Bisping E; Ikeda S; Sedej M; Wakula P; McMullen JR; Tarnavski O; Sedej S; Izumo S; Pu WT; Pieske B
    J Biol Chem; 2012 Mar; 287(13):9827-9834. PubMed ID: 22228770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MITF interacts with the SWI/SNF subunit, BRG1, to promote GATA4 expression in cardiac hypertrophy.
    Mehta G; Kumarasamy S; Wu J; Walsh A; Liu L; Williams K; Joe B; de la Serna IL
    J Mol Cell Cardiol; 2015 Nov; 88():101-10. PubMed ID: 26388265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SIRT6 suppresses phenylephrine-induced cardiomyocyte hypertrophy though inhibiting p300.
    Shen P; Feng X; Zhang X; Huang X; Liu S; Lu X; Li J; You J; Lu J; Li Z; Ye J; Liu P
    J Pharmacol Sci; 2016 Sep; 132(1):31-40. PubMed ID: 27094368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Piceatannol attenuates cardiac hypertrophy in an animal model through regulation of the expression and binding of the transcription factor GATA binding factor 6.
    Kee HJ; Park S; Kang W; Lim KS; Kim JH; Ahn Y; Jeong MH
    FEBS Lett; 2014 May; 588(9):1529-36. PubMed ID: 24662306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcription factor CHF1/Hey2 suppresses cardiac hypertrophy through an inhibitory interaction with GATA4.
    Xiang F; Sakata Y; Cui L; Youngblood JM; Nakagami H; Liao JK; Liao R; Chin MT
    Am J Physiol Heart Circ Physiol; 2006 May; 290(5):H1997-2006. PubMed ID: 16603706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acetylation of GATA-4 is involved in the differentiation of embryonic stem cells into cardiac myocytes.
    Kawamura T; Ono K; Morimoto T; Wada H; Hirai M; Hidaka K; Morisaki T; Heike T; Nakahata T; Kita T; Hasegawa K
    J Biol Chem; 2005 May; 280(20):19682-8. PubMed ID: 15764815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Promyelocytic leukemia zinc finger protein activates GATA4 transcription and mediates cardiac hypertrophic signaling from angiotensin II receptor 2.
    Wang N; Frank GD; Ding R; Tan Z; Rachakonda A; Pandolfi PP; Senbonmatsu T; Landon EJ; Inagami T
    PLoS One; 2012; 7(4):e35632. PubMed ID: 22558183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The dietary compound curcumin inhibits p300 histone acetyltransferase activity and prevents heart failure in rats.
    Morimoto T; Sunagawa Y; Kawamura T; Takaya T; Wada H; Nagasawa A; Komeda M; Fujita M; Shimatsu A; Kita T; Hasegawa K
    J Clin Invest; 2008 Mar; 118(3):868-78. PubMed ID: 18292809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phosphorylation of the chromatin remodeling factor DPF3a induces cardiac hypertrophy through releasing HEY repressors from DNA.
    Cui H; Schlesinger J; Schoenhals S; Tönjes M; Dunkel I; Meierhofer D; Cano E; Schulz K; Berger MF; Haack T; Abdelilah-Seyfried S; Bulyk ML; Sauer S; Sperling SR
    Nucleic Acids Res; 2016 Apr; 44(6):2538-53. PubMed ID: 26582913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted inhibition of ANKRD1 disrupts sarcomeric ERK-GATA4 signal transduction and abrogates phenylephrine-induced cardiomyocyte hypertrophy.
    Zhong L; Chiusa M; Cadar AG; Lin A; Samaras S; Davidson JM; Lim CC
    Cardiovasc Res; 2015 May; 106(2):261-71. PubMed ID: 25770146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GATA4 regulates ANF expression synergistically with Sp1 in a cardiac hypertrophy model.
    Hu X; Li T; Zhang C; Liu Y; Xu M; Wang W; Jia Z; Ma K; Zhang Y; Zhou C
    J Cell Mol Med; 2011 Sep; 15(9):1865-77. PubMed ID: 20874724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of cardiomyocyte hypertrophy by protein arginine methyltransferase 5.
    Chen M; Yi B; Sun J
    J Biol Chem; 2014 Aug; 289(35):24325-35. PubMed ID: 25012667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.